Newsfeeds - Spark Newswire

1 minute read

Takeda’s Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion

Today, 11:04 PM

The FDA has approved Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) Exkivity (mobocertinib) for non-small cell lung cancer (NSCLC) settings. The approval comes…

TAK

4 minute read

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

ABSI

6 minute read

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)

ABSI

3 minute read

5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More

By Chris Katje

Today, 11:04 PM

Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billion. This was the third quarter in a row that this happened globally and in the U.S.

AAPL